Peg-3350, Electrolytes, And Ascorbate Kit
Pricing Report NDC 68682-201-75

Latest NADAC: $77.46100 per EA · Effective Sep 17, 2025
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Peg-3350, Electrolytes, And Ascorbate (NDC 68682-201-75) is $77.46100 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 17, 2025.

As a a human prescription drug provided by Oceanside Pharmaceuticals, this medication is distributed in a 1 KIT in 1 CONTAINER * 1 L in 1 POUCH * 1 L in 1 POUCH configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$77.46100
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 17, 2025
Data Status
As of Oct 01, 2025
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
68682-201-75
Description
1 KIT in 1 CONTAINER * 1 L in 1 POUCH * 1 L in 1 POUCH
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2020, the NADAC wholesale price for (NDC ) has moved within a range of $52.14846 to $91.43800 per EA. Over this 4 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$52.1485 - $91.4380
Market Volatility
75.34% Variance
Latest Trend
1.46%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 17, 2025 $77.46100 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $78.60650 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2025 $79.44533 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $76.11683 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $74.34539 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2025 $71.07539 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $69.72072 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $63.13371 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $61.09994 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $64.22877 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2024 $63.39167 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2024 $75.58900 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026